TC
WST icon

Truvestments Capital’s West Pharmaceutical WST Stock Holding History

Truvestments Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$10K Buy
+80
New +$8.97K ﹤0.01% 642

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Truvestments Capital's WST Position: Q3 2018 in Review

Truvestments Capital opened a new position in West Pharmaceutical (WST) in Q3 2018: 80 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #642 among its holdings.

355 funds tracked by Wall St. Rank hold WST as of Q3 2018.

  • Truvestments Capital held 80 shares of West Pharmaceutical worth $10K as of Q3 2018.
  • West Pharmaceutical was a new Truvestments Capital position in Q3 2018.
  • West Pharmaceutical made up ﹤0.01% of Truvestments Capital's portfolio in Q3 2018, its #642 holding.
  • 355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2018.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.